ETS1 and ovarian cancer: These findings indicate that LV-ETS1 Exos enhance omental metastasis in ovarian cancer by modulating the pro-tumorigenic effects of macrophages through integrin αvβ5/AKT/Sp1 signaling (Fig. 8).